- CEO
- Steven I. Hochberg CPA, CPA,
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 780 Third Avenue New York City NY United States of America 10010
- IPO Date
- Mar 11, 2020
- Business
- DFP Healthcare Acquisitions Corp. (DFPHU) is a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting opportunities in the healthcare industry encompassing services, therapeutics, devices, diagnostics, and animal health; it does not currently have significant independent operations or generate revenue. Incorporated in 2019 and headquartered in New York, New York, the company raised $230 million in its initial public offering in March 2020, with units trading under the ticker DFPHU on the OTC market, sponsored by an affiliate of Deerfield Management Company, L.P., a healthcare-focused investment firm, and healthcare executive Richard Barasch. In a major development completed on November 12, 2021, DFP Healthcare Acquisitions Corp. merged with The Oncology Institute, Inc., in a reverse merger transaction valuing the combined entity at approximately $842 million on a pro forma enterprise basis, after which the surviving company, renamed The Oncology Institute, began trading on Nasdaq under new tickers (TOI); the deal included a $275 million PIPE investment from healthcare investors such as Fidelity Management & Research Company LLC, Deerfield Management, and Redmile Group, LLC, to fuel expansion in value-based oncology care services across the U.S. As of late 2025, DFP Healthcare Acquisitions Corp. units (DFPHU) continue to trade on the OTC market with low volume and a market capitalization around $38.5 million, amid indications of potential delisting and no further disclosed business combinations or operational shifts since the 2021 merger.